Statistics about Health, Pharma & Medtech in Japan
Statistics
- Taisho Pharmaceutical's employee number FY 2013-2020
- Alfresa's manufacturing business net sales FY 2014-2018
- Taisho Pharmaceutical's net income FY 2013-2020
- Taisho Pharmaceutical's R&D expenditures FY 2013-2020
- Number of life sciences PCT applications in Japan by area 2009-2012
- Alfresa's net sales FY 2017, by segment
- Alfresa's operating profit FY 2017, by segment
- Alfresa's operating profit FY 2013-2018
- Alfresa's market capitalization FY 2013-2017
- Number of blood donors Japan 2013-2021
- Estimated amount of blood donations Japan 2021, by type
- Alfresa's self-medication products wholesale business net sales FY 2014-2018
- Estimated amount of blood donations Japan 2013-2021
- Alfresa's net sales FY 2013-2022
- Taisho Pharmaceutical's operating profit FY 2013 to 2018
- Number of blood donors Japan 2021, by gender
- Non-prescription drugs market shipment value in Japan 2010-2019
- Drug production value of allergic agents Japan 2016, by category
- Usage volume influenza vaccination Japan 2013-2022
- Revenue in the vitamins & minerals segment Japan 2018-2029
- Revenue in the OTC pharmaceuticals market Japan 2018-2029
- Antipyretic analgesics domestic shipment value in Japan 2010-2019
- Drug production value of digestive organ agents Japan 2016, by category
- Drug production value share of digestive organ agents Japan 2018, by category
- Pharmaceutical drug production value Japan 2018, by prefecture
- Digestive medicine domestic shipment value in Japan 2010-2019
- Wholesale value of OTC drugs Japan FY 1990-2022
- OTC pharma market revenue APAC 2023, by country
- Supply volume of seasonal influenza vaccination Japan 2014-2023
- Shionogi's net sales FY 2018-2021
- Shionogi's operating income FY 2018-2021
- Shionogi's profit FY 2018-2021
- Sumitomo Pharma's gross profit FY 2016-2023
- Shionogi's ROE FY 2018-2021
- Revenue in the hand sanitizer segment Japan 2018-2029
- Sumitomo Pharma's revenue FY 2016-2023
- Number of prescription drugs approved by PMDA Japan FY 2015-2022, by type
- OTC drugs market share in Japan 2015 by product
- OTC drugs market shipment value in Japan 2010-2019
- Sumitomo Pharma's R&D expenses FY 2016-2023
- Sumitomo Pharma's operating profit FY 2016-2023
- Sumitomo Pharma's total assets FY 2016-2023
- Drug production value of sensory organ agents Japan 2016, by category
- Sumitomo Pharma's revenue FY 2023, by region
- Shionogi's R&D expenses FY 2018-2021
- Production value of pharmaceuticals Japan 2021, by prefecture
- Wholesale value of pharmaceuticals Japan FY 2022, by category
- Preferred frequency of taking Chinese herbal medicine Japan 2023
- Share of prescription and OTC drug in wholesale Japan FY 2013-2022
- Kobayashi Pharmaceutical's sales FY 2023, by business segment
- Kobayashi Pharmaceutical's sales FY 2023, by region
- Production value of cardiovascular agents Japan 2019-2022
- Share of drug production value Japan 2013-2022, by type
- Share of drug production value Japan 2022, by drug form
- Share of drug production value Japan 2022, by category
- Awareness of the term drug loss and drug lag Japan 2023
- Production value of prescription drugs Japan 2013-2022
- Number of BTC and OTC drugs approved by PMDA Japan FY 2013-2022
- Median approval time of new drugs Japan 2003-2022, by type
- Drug production value share of antibiotics Japan 2016, by category
- Share of the volume of generics in the prescription drug market Japan 2011-2023
- Wholesale value of pharmaceuticals Japan FY 2015-2022
- Kobayashi Pharmaceutical's total assets FY 2019-2023
- Share of seniors who faced mistakes purchasing health supplements Japan 2023
- Production value of cardiovascular agents Japan 2022, by type
- Frequency of senior Japanese people taking health supplements Japan 2023
- Most common reasons to take Chinese medicine for young people Japan 2023
- Share of clinical trials in selected countries APAC 1999-2022, by participants
- Share of clinical trials in selected countries APAC 1999-2022, by health category
- Pharma market revenue APAC 2023, by country
- Pharma sales value of manufacturers and sellers Japan FY 2022, by sales region
- Pharma sales value of manufacturers and sellers Japan FY 2022, by product type
- Production value of medical drugs Japan 2021, by production place
- Share of young people who have taken Chinese medicine Japan 2023
- Drug production value share of vitamins Japan 2019, by category
- eHealth market revenue in Japan 2020-2029, by segment
- Revenue in the Pharmaceuticals market Japan 2018-2029
- Number of new drugs approved by PMDA Japan FY 2014-2022
- Sales value of major prescription drugs Japan FY 2022
- Production value of biological products Japan 2021, by type
- Production value of antimetabolites Japan 2019-2022
- Production value of antitumor plant component preparation Japan 2019-2022
- Production value of metabolic drugs Japan 2019-2022
- Production value of metabolic drugs Japan 2022, by type
- Production value of central nervous system drugs Japan 2019-2022
- Production value of central nervous system drugs Japan 2022, by type
- Drug production value of traditional Chinese medicines Japan 2013-2022
- Number of in vitro diagnostics approved by PMDA Japan FY 2013-2022
- Production value of drugs for blood and body fluids Japan 2019-2022
- Total revenue of Perjeta 2018-2022, by region
- Number of pharmaceutical products approved by PMDA Japan FY 2022, by type
- Production value of biological products Japan 2019-2021
- Drug production value share of hormones Japan 2021, by category
- Revenue in the pharmaceuticals market Japan 2018-2029
- Production value of gastrointestinal medicines Japan 2019-2022
- Production value of gastrointestinal medicines Japan 2022, by type
- Production value of oncology drugs Japan 2019-2021
- Production value of drugs for blood and body fluids Japan 2022, by type
- Designated quasi drugs market shipment value in Japan 2010-2019
- Production value of oncology drugs Japan 2021, by type